SE451723B - 4-AMINOPYRAZOLIDE INGREDIENTS USED AS INTERMEDIATES FOR THE PREPARATION OF N- (4-PYRAZOLIDINYL) BENZAMIDES - Google Patents

4-AMINOPYRAZOLIDE INGREDIENTS USED AS INTERMEDIATES FOR THE PREPARATION OF N- (4-PYRAZOLIDINYL) BENZAMIDES

Info

Publication number
SE451723B
SE451723B SE8303564A SE8303564A SE451723B SE 451723 B SE451723 B SE 451723B SE 8303564 A SE8303564 A SE 8303564A SE 8303564 A SE8303564 A SE 8303564A SE 451723 B SE451723 B SE 451723B
Authority
SE
Sweden
Prior art keywords
chloride
chloroform
amino
preparation
mixture
Prior art date
Application number
SE8303564A
Other languages
Swedish (sv)
Other versions
SE8303564D0 (en
SE8303564L (en
Inventor
C D Lunsford
Jr A D Cale
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of SE8303564D0 publication Critical patent/SE8303564D0/en
Publication of SE8303564L publication Critical patent/SE8303564L/en
Publication of SE451723B publication Critical patent/SE451723B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/04Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Description

451 723 R? kan beteckna exempelvis hydroxiv cyano, nitro,-amino, fluoro, kloro, bromo, trifluormetyl, lägre alkyl, lägre alkoxi, sulfamoyl eller acetamido, I ~ 4 I varvid R3 lämpligen är lika eller olika grupper och n betecknar 0, 1, 2 eller 3. 451 723 R? may represent, for example, hydroxy cyano, nitro, amino, fluoro, chloro, bromo, trifluoromethyl, lower alkyl, lower alkoxy, sulfamoyl or acetamido, I-4 I wherein R 3 is suitably the same or different groups and n represents 0, 1, 2 or 3.

De anti-emetiska egenskaperna bestämdes med användning av en modi- * fikation av den metod som beskrives-av Chen och Enxor, J. Pharmac.The antiemetic properties were determined using a modification of the method described by Chen and Enxor, J. Pharmac.

Exp. Ther. gå, 245-250 (1950) och Leonard-och-medarbetare, J. Phar- mac. Exp. Ther. lâí, 339-345 (1966).Exp. Ther. go, 245-250 (1950) and Leonard-and-co-workers, J. Phar- mac. Exp. Ther. lâí, 339-345 (1966).

Den gastriska tömningsaktiviteten bestämdes med följande förfaran- de. Hon Spraque-Dawlay-råttor vägande från 117-221 g fick svälta 24 timmar i individuella siktbottnade burar med vatten ad libitum.The gastric emptying activity was determined by the following procedure. She Spraque-Dawlay rats weighing from 117-221 g were allowed to starve for 24 hours in individual sieve-bottomed cages with water ad libitum.

Djuren arrangerades i grupper om åtta. Vid tidpunkten_noll admi- nistrerades 9 mg/kg av testföreningen intraperitonealt till råttor- na i 5% akacia (0,4 ml/100 g kroppsvikt). Kontrollgruppen erhöll akacia enbart, 4 ml/kg intraperitonealt. 30 minuter efter doserna fick råttorna oralt med magrör 3 ml av ett testmål bestående av metylcellulosa, till vilken hade satts-köttbuljong, casein, pulv- riserat socker och majsstärkelse för att ge en halvfast homogen pasta. 60 minuter efter testmålet (efter en total tid av 90 minu- ter), dödades râttorna genom cervikal dislokation, laparotomise- rades och magen avlägsnades. Den fulla magen vägdes på en analytisk balansvåg efter vilken den uppskars och tömdes, varefter den tom- ma magen vägdes. Skillnaden mellan full och tom magvikt represen- terade mängden mat kvarvarande i magen och drogs ifrån vikten på 3 ml av testmâlet, varvid erhölls den mängd av målet som uttömts ur magen under testperíoden.The animals were arranged in groups of eight. At time zero, 9 mg / kg of the test compound was administered intraperitoneally to the rats in 5% acacia (0.4 ml / 100 g body weight). The control group received acacia alone, 4 ml / kg intraperitoneally. Thirty minutes after dosing, the rats were given orally by gavage 3 ml of a test target consisting of methylcellulose, to which had been added broth, casein, powdered sugar and corn starch to give a semi-solid homogeneous paste. 60 minutes after the test goal (after a total time of 90 minutes), the rats were killed by cervical dislocation, laparotomized and the stomach removed. The full stomach was weighed on an analytical balance scale after which it was cut and emptied, after which the empty stomach was weighed. The difference between full and empty stomach weight represented the amount of food remaining in the stomach and was subtracted from the weight of 3 ml of the test meal, whereby the amount of the meal emptied from the stomach was obtained during the test period.

I föreliggande ansökan avser lägre alkyl grupper med 1-4 kolato- mer.In the present application, lower alkyl groups refer to 1-4 carbon atoms.

'\$\ I föreliggande ansökan avser uttrycket “lägre cykloalkyl" primära cykliska alkylgrupper innehållande från 4-12 kolatomer och inne- fattar sådana grupper som cyklobutyl, cyklopentyl, cyklohexyl, cykloheptyl, metylcyklopentyl, etylcyklohexyl och liknande. j) Uttrycket "lägre-alkyl" innefattar raka eller grenade kedjor med 451 7275 3 1-8 kolatomer, exempelvis metyl, etyl, propyl, isopropyl, n-bu- tyl, tertiär butyl, amyl, isoamyl, n-hexyl, n-heptyl och n-oktyl- grupper. Lägre-alkoxi-grupper har formen 0-lägre alkyl.In the present application the term "lower cycloalkyl" refers to primary cyclic alkyl groups containing from 4 to 12 carbon atoms and includes such groups as cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, methylcyclopentyl, ethylcyclohexyl and the like. J) The term "lower alkyl "includes straight or branched chains having 45 to 72 carbon atoms, for example methyl, ethyl, propyl, isopropyl, n-butyl, tertiary butyl, amyl, isoamyl, n-hexyl, n-heptyl and n-octyl groups Lower alkoxy groups have the form O-lower alkyl.

Inom ramen for uttrycket "fenyllägre-alkyl“ innefattas sådana grup- per som bensyl, fenetyl, fenpropylvfä-metylbensyl och liknande.The term "phenyl lower alkyl" includes such groups as benzyl, phenethyl, phenpropylphenmethylbenzyl and the like.

Föreliggande uppfinning avser således nya 4-amino-1,2-hydrokarbyl- pyrazolidiner (II). Föreningarna med formeln II har formeln: 2 *I “" R_N\ N I R1 II 2:2 där R betecknar lägre alkyl, lägre cykloalkyl eller fenyllägre al- kyl, där R1 betecknar lägre alkyl och R2-betecknar väte eller fe- nyl.Thus, the present invention relates to novel 4-amino-1,2-hydrocarbyl-pyrazolidines (II). The compounds of formula II have the formula: R 2 N 2 N 2 wherein R represents lower alkyl, lower cycloalkyl or phenyl lower alkyl, wherein R 1 represents lower alkyl and R 2 represents hydrogen or phenyl.

Föreningarna.med formeln II där R2 betecknar väte framställes ge- nom upphettning av en blandning av 4-halogen-1,2-hydrokarby1pyra- zolidin och koncentrerad ammoniumhydroxid i en stålbomb vid en tem- peratur frân omkring 125 till omkring 200°C under åtskilliga tim- mar.The compounds of formula II wherein R 2 represents hydrogen are prepared by heating a mixture of 4-halo-1,2-hydrocarbylpyrazolidine and concentrated ammonium hydroxide in a steel bomb at a temperature of from about 125 to about 200 ° C for several tim- mar.

Föreningarna med formeln II där R2 betecknar fenyl framställes ge- . nom att en 1,2-hydrokarbyl-4-arylsulfonyloxi-pyrazolidin och ani-~ lin eller en substituerad anilin får reagera tillsammans med ett lämpligt lösningsmedel. 1,2-hydrokarbyl-4-arylsulfonylogi-pyrazo- lidin framställes allmänt genom att natriumsaltet av 1,2-hydrokar- byl-4-pyrazolidinol får reagera med bensensulfonylklorid eller p- -tolylsulfonylklorid i ett torrt aprotiskt lösningsmedel såsom toluen. ' 1,2-hydrokarbyl-4-pyrazolidinolerna från vilka respektive 4-amino- pyrazolidinoler framställes är antingen visade i eller kan fram- 451 72; ställas med det förfarande som visas i amerikanska patentskrif- ten 3.660.426.The compounds of formula II wherein R2 represents phenyl are prepared. by reacting a 1,2-hydrocarbyl-4-arylsulfonyloxy-pyrazolidine and aniline or a substituted aniline together with a suitable solvent. 1,2-Hydrocarbyl-4-arylsulfonylogy-pyrazolidine is generally prepared by reacting the sodium salt of 1,2-hydrocarbyl-4-pyrazolidinol with benzenesulfonyl chloride or p--tolylsulfonyl chloride in a dry aprotic solvent such as toluene. The 1,2-hydrocarbyl-4-pyrazolidinols from which the respective 4-aminopyrazolidinols are prepared are either shown in or can be prepared; by the procedure set forth in U.S. Pat. No. 3,660,426.

Framställningen av hensanidoföreningarna med formeln I kan ske ge- nom att en 4-amino-1,2-hydrokarbylpyrazolidin II sättes i kontakt med en lämplig substituerad bensoylklorid III enligt reaktions- schemat som följer: A I cooc1 _ R I i ' i 3.. ' <3) NH . R R-N / 3 NWC-Cï f* _ N + \\ (R )n.__) R_å | _ W ~N Rï II '111 I där R, R1, R2 och R3 och n tidigare definierats och där R3 icke kan vara primär amin.The preparation of the hensanido compounds of formula I can be effected by contacting a 4-amino-1,2-hydrocarbylpyrazolidine II with an appropriately substituted benzoyl chloride III according to the reaction scheme as follows: AI cooc1 - RI i 'i 3 ..' <3) NH. R R-N / 3 NWC-Cï f * _ N + \\ (R) n .__) R_å | Where R, R 1, R 2 and R 3 and n are previously defined and where R 3 cannot be primary amine.

Föreningarna med formeln I där-R3 är primär amino framställes all- mänt genom katalytisk hydrogenering av föregångarföreningen enligt formel I, där R3 betecknar nitro..Alternativt kan en förening med formeln I framställas med R3 som en acetamidogrupp och denna för- ening hydrolyseras med utspädd syra för bildning av en aminogrupp.The compounds of formula I wherein -R 3 is primary amino are generally prepared by catalytic hydrogenation of the precursor compound of formula I, wherein R 3 represents nitro. Alternatively, a compound of formula I may be prepared with R 3 as an acetamido group and this compound is hydrolyzed with dilute acid to form an amino group.

De substituerade bensoylkloriderna III, användbara vid framställ- ning av N-(4-pyrozolidinyl)bensamider, är antingen kända förening- ar eller kan framställas på i och för siglkänt sätt och innefat- tar men begränsas inte av följande uppräknade föreningar: 2-f1uorobensoylklorid_ a-bromobensoylklória 4-bromobensoylklorid 3,5-dinitrobensoylklorid 3,4-diklorobensoylklorid 3,4-dietoxibensoylklorid 3-trifluorometylbensoylklorid 4-tertiär butylbensoylklorid 4-butoxibensoylklorid I! 1451 723 2,4-dimetoxibensoylklorid 4fmetylbensoylklorid 4-cyanobensoylklorid' 2-metoxi-5-sulfamoylbensoylklorid 2-metoxi-4-dimetylaminobensoylklorid 2-metoxi-4-nitrobensoylklorid 2-metoxi-3-fluoro-5-klorobensoylklorid 2-etoxi-4~brbmobensoylklorid 2-metoxi-3-acetamido-5-trifluorometylbensoylklorid. 4-kloro-1,2-dietylpyrazolidin _ En lösning av trifenylfosfin (52 g; 0,2 mol) i 150 ml kloroform behandlades med klcrgas, vilket åtföljdes av en temperaturhöjning hos blandningen till 60° till dess överskottsklorgas uppträdde över blandningens yta. Luft fick passera blandningen till dess att den gröngula gasen försvann. Till den kylda (30°C)omrörda bland- ningen sattes droppvis 28,8 g (0,2 mol) 1,2-dietyl-4-pyrazolidinol med en hastighet vilken orsakade att reaktionsblandningen sjönk till 40°C. Efter tillsatsen av den omrörda lösningen kokades under återflöde två timmar, kyldes till rumstemperatur och extraherades med_vatten¿ De sammanslagna vattenextrakten gjordes basiska med koncentrerad natriumhydroxidlösning och den basiska blandningen extraherades med kloroform. De torkade kloroformextrakten (natri- umsulfat) koncentrerades vid förminskat tryck och återstående mate- rial destillerades vid 92-94°C/30 mm Hg, varvid erhölls 24,5 g (75%) av produkten.The substituted benzoyl chlorides III, useful in the preparation of N- (4-pyrozolidinyl) benzamides, are either known compounds or can be prepared in a known manner and include but are not limited to the following listed compounds: 2-fluorobenzoyl chloride α-bromobenzoyl chloride 4-bromobenzoyl chloride 3,5-dinitrobenzoyl chloride 3,4-dichlorobenzoyl chloride 3,4-diethoxybenzoyl chloride 3-trifluoromethylbenzoyl chloride 4-tertiary butylbenzoyl chloride 4-butoxybenzoyl chloride I! 1451 723 2,4-Dimethoxybenzoyl chloride 4-methylbenzoyl chloride 4-cyanobenzoyl chloride 2-methoxy-5-sulfamoylbenzoyl chloride 2-methoxy-4-dimethylaminobenzoyl chloride 2-methoxy-4-nitrobenzoyl chloride 2-methoxy-5-oxy-5-oxy-5-oxy-5-methoxy brmobenzoyl chloride 2-methoxy-3-acetamido-5-trifluoromethylbenzoyl chloride. 4-Chloro-1,2-diethylpyrazolidine A solution of triphenylphosphine (52 g; 0.2 mol) in 150 ml of chloroform was treated with chlorine gas, followed by a temperature increase of the mixture to 60 ° until excess chlorine gas appeared over the surface of the mixture. Air was allowed to pass through the mixture until the greenish-yellow gas disappeared. To the cooled (30 ° C) stirred mixture was added dropwise 28.8 g (0.2 mol) of 1,2-diethyl-4-pyrazolidinol at a rate which caused the reaction mixture to drop to 40 ° C. After the addition of the stirred solution, the mixture was refluxed for two hours, cooled to room temperature and extracted with water. The combined aqueous extracts were basified with concentrated sodium hydroxide solution and the basic mixture was extracted with chloroform. The dried chloroform extracts (sodium sulfate) were concentrated under reduced pressure, and the remaining material was distilled at 92-94 ° C / 30 mm Hg to give 24.5 g (75%) of the product.

Analys; s~eräknat för c7H'-15N2c1= c Vs1f,ss~;« an~~9',.2-9;~- N 17,22 nfhånetf -' c 51,45; n 9,30; N 17,29.Analysis; s ~ calculated for c7H'-15N2c1 = c Vs1f, ss ~; «an ~~ 9 ',. 2-9; ~ - N 17,22 nfhånetf -' c 51,45; n 9.30; N 17.29.

Exempel 1 4-amino-1,2-dietylpyrazolidin En blandning av 100 g (0,615 mol) 4-kloro-1,2-dietylpyrazolidin och 200 ml koncentrerad ammoniumhydroxid i en sluten stålbehålla- re upphettades till 150°C under ca 36 timmar. Den kylda reaktions- blandningen extraherades med isopropyleter, den vattenhaltiga fa- sen mättades med kaliumkarbonat och extraherades kontinuerligt med 451_ 723 kloroform under 6 timmar. Det torkade kloroformextraktet (natri- umsulfat) koncentrerades vid förminskat tryck och återstoden destillerades vid 113-115°C/40 mm Hg, varvid erhölls 40,5 g (45,5%) av produkten. V Exempel 2 I 4-amino-1,2-dimetylpyrazolidin En blandning av 300 g (2,22 mol) 4-kloro-1,2-dimetylpyrazolidin och 600 ml koncentrerad ammoniumhydronid upphettades till 1§0°C under 18 timmar i en stâlbomb. Den kylda blandningen mättades med kaliumkarbonat och extraherades kontinuerligt under 18 timmar med kloroform. Aterstoden material efter koncentration av kloroform- extraktet var destillerat vid 90-100°C/40 mm Hg, varvid erhölls 73 g av produkten.Example 1 4-Amino-1,2-diethylpyrazolidine A mixture of 100 g (0.615 mol) of 4-chloro-1,2-diethylpyrazolidine and 200 ml of concentrated ammonium hydroxide in a closed steel container was heated to 150 ° C for about 36 hours. The cooled reaction mixture was extracted with isopropyl ether, the aqueous phase was saturated with potassium carbonate and extracted continuously with 451-723 chloroform for 6 hours. The dried chloroform extract (sodium sulfate) was concentrated under reduced pressure and the residue was distilled at 113-115 ° C / 40 mm Hg to give 40.5 g (45.5%) of the product. Example 2 In 4-amino-1,2-dimethylpyrazolidine A mixture of 300 g (2.22 mol) of 4-chloro-1,2-dimethylpyrazolidine and 600 ml of concentrated ammonium hydronide was heated to 100 ° C for 18 hours in a steel bomb. The cooled mixture was saturated with potassium carbonate and extracted continuously for 18 hours with chloroform. The residual material after concentration of the chloroform extract was distilled at 90-100 ° C / 40 mm Hg to give 73 g of the product.

Exempel 3 4-amino-1-bensyl-2-metylpyrazolidin 4-amino-1-bensyl-2-metylpvrazolidin, kokpunkt 115-125°C/1,0 mm Hg framställdes ur 1-bensyl-2-metyl-4-pyrazolidinol enligt framställ- ning 1 och Exempel 1. 7 Exempel 4 4-amino-1-cyklohexyl-2-metylpyrazolidinfumarat 4-amino-1-cyklohexyl-2-metylpyrazolidin, kokpunkt 90-100°C/0,5-1,0 mm Hg framställdes ur 1-cyklohexyl-2-metylpyrazolidinol enligt framställning 1 och Exempel 1. Furamatsaltet smälte vid 149-151°C.Example 3 4-Amino-1-benzyl-2-methylpyrazolidine 4-amino-1-benzyl-2-methylpyrazolidine, b.p. 115-125 ° C / 1.0 mm Hg was prepared from 1-benzyl-2-methyl-4-pyrazolidinol according to Preparation 1 and Example 1. 7 Example 4 4-amino-1-cyclohexyl-2-methylpyrazolidine fumarate 4-amino-1-cyclohexyl-2-methylpyrazolidine, b.p. 90-100 ° C / 0.5-1.0 mm Hg was prepared from 1-cyclohexyl-2-methylpyrazolidinol according to Preparation 1 and Example 1. The furamate salt melted at 149-151 ° C.

H Exempel 5 4-amino-1-isopropyl-2-metylpyrazolidin 4-amino-1-isopropyl-2-metylpyrazolidin, kokpunkt 110-115°C/50 mm Hg framställdes ur 1-isopropyl-2-metylpyrazolidinol enligt fram- ställning 1 och Exempel 1.H Example 5 4-Amino-1-isopropyl-2-methylpyrazolidine 4-amino-1-isopropyl-2-methylpyrazolidine, b.p. 110-115 ° C / 50 mm Hg was prepared from 1-isopropyl-2-methylpyrazolidinol according to Preparation 1 and Example 1.

Exempel 6 När i Exempel 1 i stället för koncentrerad ammoniumhydroxid ekvi- molära mängder av metylamin i metanol användes, erhölls 4-metyl- amino-1,2-dietylpyrazolidin. I 'ah 451l723 Exemgel 7 4-fiuorq-N-(1,2-aietyl-4-pyrazoiiainyl5bensamia En lösning av 10 g (0,026 mol) 1,2-dietyl-4-ftalimidopyrazolidin- maleat i 25 ml GN saltsyra kokades under återflöde 2 timmar, var- efter den resulterande blandningen_kyldes och filtrerades. Filter- kakan tvättades med vatten, vilket kombinerades med den sura lös-H ningen; Den sura lösningen gjordes basisk med utspädd natriumhydr- okid och kyldes med is. Till den återstående lösningen sattes 8,2 g (0,052 mol) p-fluorobensoylklorid och blandningen skakades under 10 minuter. Den resulterande blandningen extraherades med_kloro- form, kloroformen utspäddes med en lika stor volym isopropyleter och den resulterande lösningen-extraherades~med utspädd saltsyra.Example 6 When in Example 1 equimolar amounts of methylamine in methanol were used instead of concentrated ammonium hydroxide, 4-methylamino-1,2-diethylpyrazolidine was obtained. Example 45 7 4-Fluoro-N- (1,2-ethyl-4-pyrazolinyl) benzamide A solution of 10 g (0.026 mol) of 1,2-diethyl-4-phthalimidopyrazolidine maleate in 25 ml of GN hydrochloric acid was refluxed 2 hours, after which the resulting mixture was cooled and filtered, the filter cake was washed with water, which was combined with the acidic solution; The acidic solution was basified with dilute sodium hydroxide and cooled with ice. To the remaining solution was added 8 .2 g (0.052 mol) of p-fluorobenzoyl chloride and the mixture was shaken for 10 minutes The resulting mixture was extracted with chloroform, the chloroform was diluted with an equal volume of isopropyl ether and the resulting solution was extracted with dilute hydrochloric acid.

Syrafasen gjordes basisk med utspädd natriumhydroxid och extrahe- rades med kloroform.~Kloroformen torkades (natriumsulfat) och kon- centrerades. Årerstoden kristalliserades ur isooktan-isopropyleter och omkristalliserades ur isooktan-isopropyleter innehållande någ- ra fâ droppar etylacetat och gjordes klar genom behandling med ak- tivt kal. Produkten (2,0 g; 29%) smaite vid 114-11s°c.The acid phase was basified with dilute sodium hydroxide and extracted with chloroform. The chloroform was dried (sodium sulfate) and concentrated. The vein residue was crystallized from isooctane-isopropyl ether and recrystallized from isooctane-isopropyl ether containing a few drops of ethyl acetate and clarified by treatment with activated carbon. The product (2.0 g; 29%) melted at 114-11 ° C.

I Analys: Beräknat för C14H20N3OF: C 63,38; H 7,607' N 15,84 - Erhållet: C 63,36; H 7,61; N 15,96.Analysis: Calculated for C 14 H 20 N 3 OF: C 63.38; H 7.607, N 15.84 - Found: C 63.36; H 7.61; N 15.96.

Exemgel 8 3,4,5-trimetoxi-N-(1,2-dimetyl-4-pyrazolidinyl)bensamid Till 10-g (0,09 mol).4-amino-1,2-dimetylpyrazolidin i kloroform sattes under omröring 20,7 g (0,09 mol) 3,4,5-trimetoxibensoylk1o- rid. Efter 30 minuters omröring extraherades lösningen med utspädd natriumhydroxid. Kloroformlöshïngen"törkades (natriumsu1fatï}“fi1t-' rerades och filtratet-koncentrerades. Det resulterande kristallina materialet omkristalliserades ur lika stora mängder etylacetat och isopropyleter. Produkten (12,1 g; 44%) smälte vid 163-166°C.Example 8 3,4,5-Trimethoxy-N- (1,2-dimethyl-4-pyrazolidinyl) benzamide To 10-g (0.09 mol) of 4-amino-1,2-dimethylpyrazolidine in chloroform was added with stirring. 7. g (0.09 mol) of 3,4,5-trimethoxybenzoyl chloride. After stirring for 30 minutes, the solution was extracted with dilute sodium hydroxide. The chloroform solution was dried (sodium sulfate), filtered and the filtrate concentrated. The resulting crystalline material was recrystallized from equal amounts of ethyl acetate and isopropyl ether. The product (12.1 g; 44%) melted at 163-166 ° C.

Analys; Beräknat för c15H23N3o4= c 58,24; H 7,49; 'N 13,58 Erna11et= c 58,20; H 7,45; N 13,19. 451 723 'nxemgel 9 4-nitro-N-(1,2-dietyl-4-pyrazolidinyl)bensamidhydroklorid Till en lösning av 40,5 g (0,28 mol) 4-amino-1,2-dietylpyrazolidin i 200 ml kloroform sattes under omröring 52 g (0,28 mol) p-nitro- bensylklorid i 200 ml kloroform. Lösningen tilläts stå över nat- ten och extraherades sedan med utspådd natriumhydroxid. Klorofor- men torkades (natriumsulfat) och koncentrerades. Aterstoden kris- talliserades tvâ gånger ur isopropyleter-etylacetat, varvid erhölls 73 g (80%) av den fria basen. ' 7 ' H Analys: Beräknat för C14H20N403: C 57,52; H 6,90; N 19,17 Erhä11et=A . c 57,56; H 6,94; N 18,99.Analysis; Calculated for c 15 H 23 N 3 O 4 = c 58.24; H 7.49; A 13.58 Erna11et = c 58.20; H 7.45; N 13.19. 4-Nitro-N- (1,2-diethyl-4-pyrazolidinyl) benzamide hydrochloride To a solution of 40.5 g (0.28 mol) of 4-amino-1,2-diethylpyrazolidine in 200 ml of chloroform 52 g (0.28 mol) of p-nitrobenzyl chloride in 200 ml of chloroform were added with stirring. The solution was allowed to stand overnight and then extracted with dilute sodium hydroxide. The chloroform was dried (sodium sulfate) and concentrated. The residue was crystallized twice from isopropyl ether-ethyl acetate to give 73 g (80%) of the free base. 7 H Analysis: Calculated for C 14 H 20 N 4 O 3: C 57.52; H 6.90; N 19.17 Erhä11et = A. c 57.56; H 6.94; N 18.99.

Basen omvandlades till hydrokloridsalt och kristalliserades ur iso- prepylalkenel, vilken smälte vid 189-191°c'(sönderde1ning).The base was converted to the hydrochloride salt and crystallized from isopropyl alkenel, melting at 189-191 ° C (dec.).

Analys: Beräknat för c14H21N4o3c1= c 51,14;-' H 6,44; N 17,04 Erhâllet: C 50,96; H 6,59; N 16,58. .+h-Analysis: Calculated for c 14 H 21 N 4 O 3 Cl = c 51.14; - H 6.44; N 17.04 Found: C 50.96; H 6.59; N 16.58. + h-

Claims (1)

1. 0 451 723 Patentkräv _4-amihopyrazólidin'Éed formeln där R betecknar lägre alkyl, lägre cykloalkyl eller fenyl~ lägre alkyl, där Rï betecknar lägre alkyl och där Rz be- tecknar väte eller fenyl.A 45-amihopyrazolidine has the formula wherein R represents lower alkyl, lower cycloalkyl or phenyl-lower alkyl, wherein R 1 represents lower alkyl and wherein R 2 represents hydrogen or phenyl.
SE8303564A 1977-08-19 1983-06-21 4-AMINOPYRAZOLIDE INGREDIENTS USED AS INTERMEDIATES FOR THE PREPARATION OF N- (4-PYRAZOLIDINYL) BENZAMIDES SE451723B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82603177A 1977-08-19 1977-08-19
US90036978A 1978-04-26 1978-04-26
US93012578A 1978-08-01 1978-08-01

Publications (3)

Publication Number Publication Date
SE8303564D0 SE8303564D0 (en) 1983-06-21
SE8303564L SE8303564L (en) 1983-06-21
SE451723B true SE451723B (en) 1987-10-26

Family

ID=27420183

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7808694A SE444434B (en) 1977-08-19 1978-08-16 N- (4-pyrazolidinyl) benzamides
SE8303564A SE451723B (en) 1977-08-19 1983-06-21 4-AMINOPYRAZOLIDE INGREDIENTS USED AS INTERMEDIATES FOR THE PREPARATION OF N- (4-PYRAZOLIDINYL) BENZAMIDES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7808694A SE444434B (en) 1977-08-19 1978-08-16 N- (4-pyrazolidinyl) benzamides

Country Status (21)

Country Link
JP (1) JPS5441873A (en)
AU (1) AU521421B2 (en)
BR (1) BR7805288A (en)
CA (1) CA1105037A (en)
CH (2) CH639374A5 (en)
DE (1) DE2836062A1 (en)
DK (1) DK152361C (en)
ES (1) ES472686A1 (en)
FI (1) FI68044C (en)
FR (1) FR2400511A1 (en)
GB (2) GB2003153B (en)
HK (1) HK42282A (en)
IE (1) IE47430B1 (en)
MX (1) MX5469E (en)
NL (1) NL7808596A (en)
NO (1) NO149107C (en)
NZ (1) NZ188189A (en)
PH (1) PH13331A (en)
PT (1) PT68442A (en)
SE (2) SE444434B (en)
YU (1) YU41116B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309552A (en) * 1980-08-07 1982-01-05 A. H. Robins Company, Inc. Synthesis of 4-nitro-1,2-hydrocarbyl pyrazolidines and process for preparation thereof
US5126343A (en) * 1989-09-11 1992-06-30 G. D. Searle & Co. N-azabicyclo [3.3.0]octane amides of aromatic acids
JP3065506B2 (en) 1995-04-03 2000-07-17 株式会社資生堂 Pyrazolidine derivative and radical scavenger, cerebral infarction inhibitor, cerebral edema inhibitor
UY34104A (en) 2011-05-31 2013-01-03 Syngenta Participations Ag ? HETEROCYCLIC BENZAMID DERIVATIVE COMPOUNDS, PROCESSES AND INTERMEDIATES FOR PREPARATION, COMPOSITIONS AND METHODS FOR USE.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966957A (en) * 1972-04-03 1976-06-29 A. H. Robins Company, Incorporated Method for controlling emesis with N-(1-substituted-3-pyrrolidinyl)benzamides and thiobenzamides

Also Published As

Publication number Publication date
CA1105037A (en) 1981-07-14
AU521421B2 (en) 1982-04-01
IE781682L (en) 1979-02-19
HK42282A (en) 1982-10-08
PT68442A (en) 1978-09-01
NO782812L (en) 1979-02-20
GB2003153B (en) 1982-02-24
MX5469E (en) 1983-08-16
NL7808596A (en) 1979-02-21
AU3906178A (en) 1980-02-21
CH645356A5 (en) 1984-09-28
GB2003153A (en) 1979-03-07
ES472686A1 (en) 1979-03-16
CH639374A5 (en) 1983-11-15
PH13331A (en) 1980-03-13
NZ188189A (en) 1984-07-06
GB2017678B (en) 1982-03-10
NO149107B (en) 1983-11-07
IE47430B1 (en) 1984-03-21
DK366978A (en) 1979-02-20
SE444434B (en) 1986-04-14
JPS6315273B2 (en) 1988-04-04
YU198678A (en) 1983-01-21
FI68044C (en) 1985-07-10
FI68044B (en) 1985-03-29
DK152361B (en) 1988-02-22
SE8303564D0 (en) 1983-06-21
DK152361C (en) 1988-07-25
SE7808694L (en) 1979-02-20
SE8303564L (en) 1983-06-21
BR7805288A (en) 1979-04-10
GB2017678A (en) 1979-10-10
YU41116B (en) 1986-12-31
JPS5441873A (en) 1979-04-03
FR2400511A1 (en) 1979-03-16
NO149107C (en) 1984-02-22
DE2836062A1 (en) 1979-03-01
FR2400511B1 (en) 1981-09-04
FI782507A (en) 1979-02-20

Similar Documents

Publication Publication Date Title
US4423045A (en) Thiadizines
US5314886A (en) N-substituted lactams useful as cholecystokinin antagonists
PL103685B1 (en) PLANT PROTECTION
US3989698A (en) Process for preparing benzoxazines
US4207327A (en) N-(4-Pyrazolidinyl)benzamides and their amino precursors
JPS6212788B2 (en)
SE451723B (en) 4-AMINOPYRAZOLIDE INGREDIENTS USED AS INTERMEDIATES FOR THE PREPARATION OF N- (4-PYRAZOLIDINYL) BENZAMIDES
SU685146A3 (en) Method of synthesis of phenylurea
CA1108143A (en) Quinoxaline-di-h-oxides and production thereof
SE431868B (en) PROCEDURE FOR PREPARING N- (1-CYCLOHEXYL-3-PYRROLIDINYL) -BENZAMIDES WITH ANTI-MEMICAL EFFECT
US3972911A (en) N,N&#39;(Cyano-phenylene)dioxamic acids and esters
EP0315112B1 (en) Novel amide compounds
US4067995A (en) Compounds, compositions and methods of use
DE3213027A1 (en) 2,3-DISUBSTITUTED 5,6-DIHYDROIMIDAZO (2,1-B) THIAZOLE, ITS SALTS, METHOD FOR ITS OR. THEIR PRODUCTION AND THIS OR THIS CONTAINING ANTI-INFLAMMATORY AGENT
AU609758B2 (en) Benzamide derivatives
US3709917A (en) N-acyl and n-organosulfonyl mono-or di-substituted sulfamoylbenzenesulfonamides
US3384757A (en) Benzene sulfonyl ureas and process for their preparation
US2992221A (en) Polymethylene-oxoquinazolines and their production
EP0937054B1 (en) 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications
JPS62175472A (en) Novel herbicidal imidazolines
SU1156362A1 (en) Arylamides p-(2,4)-dimethoxybenzylanthranylic acids as intermediate compounds for synthesis of biological active 1-[(2 , 4 )-dimethoxybenzyl)-2-methyl-3-aryl-4-(3n)-quinazolinon perchlorates
US3597429A (en) Derivatives of tetrazolyl alkanoic acids
US3373163A (en) N-methyl-piperazides of alicyclic and heterocyclic carboxylic acids
CA1092882A (en) Diazine feed additive
US3557153A (en) N-acylated benzene-2,4-disulfonamides and process for preparing them

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8303564-2

Effective date: 19920306

Format of ref document f/p: F